R&D for Neglected Diseases: $405 Return on Investment
Sub-Saharan Africa is set to gain the most from Research and Development (R&D) investments in neglected diseases, with 75% of lives saved and 81% of Disability-Adjusted Life Years (DALYs) averted in the region. A Policy Cures Research report reveals that R&D investments from 2000-2040 are projected to save 40.7 million